CSPC PHARMACEUT.GR. ADR4
Research CSPC PHARMACEUT.GR. ADR4 (CVGU) on Bullrun: market cap EUR 10.49B, P/E 11.2, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCVGU
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 10.49B
- P/E11.2
- Dividend yield3.3%
- Financial periodFY2025
- RevenueCNY 26.01B
- Revenue growth-10.4%
- Net incomeCNY 3.88B
- Free cash flowCNY 3.55B
- Gross margin65.6%
Valuation Snapshot
latest market cap is EUR 10.49B; P/E is 11.2; dividend yield is 3.3%.
Peer valuation comparison
Latest P/E is 11.15x versus a Healthcare sector median of 24.46x (54.4% below).
Latest dividend yield is 3.33% versus a Healthcare sector median of 2.11% (57.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 26.01B | CNY 3.88B | CNY 3.55B | 65.6% | 1.36 | CNY 6.09B | CNY 641.11M | CNY 33.18B |
| FY2024 | CNY 29.01B | CNY 4.33B | CNY 1.86B | 70.0% | 1.47 | CNY 6.78B | CNY 507.33M | CNY 32.26B |
| FY2023 | CNY 31.45B | CNY 5.87B | CNY 2.29B | 70.5% | 1.98 | CNY 12.02B | CNY 706.90M | CNY 33.20B |
| FY2022 | CNY 30.94B | CNY 6.09B | CNY 4.90B | 71.9% | 2.04 | CNY 10.30B | CNY 582.54M | CNY 30.20B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 10.49B | 11.2 | 3.5% | 0.13 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.13 EUR, yield 3.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.11 CNY |
| FY2024 | 0.13 CNY |
| FY2023 | 0.11 CNY |
| FY2022 | 0.09 CNY |
| FY2021 | 0.08 CNY |
About CSPC PHARMACEUT.GR. ADR4
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CSPC PHARMACEUT.GR. ADR4's market cap?
CSPC PHARMACEUT.GR. ADR4's market capitalization is EUR 10.49B.
What is CSPC PHARMACEUT.GR. ADR4's P/E ratio?
CSPC PHARMACEUT.GR. ADR4's price-to-earnings (P/E) ratio is 11.2.
Does CSPC PHARMACEUT.GR. ADR4 pay a dividend?
CSPC PHARMACEUT.GR. ADR4 has a dividend yield of 3.3%.
What does CSPC PHARMACEUT.GR. ADR4 do?
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.